lncRNA, mRNA, ESWL,PCNL,SBF2-AS1, FENDRR-19, NLRP3.
Showing 26 - 50 of >10,000
Urinary Calculi, Percutaneous Nephrolithotomy Trial in Hengyang (Without reverse insertion of a ureteral catheter)
Recruiting
- Urinary Calculi
- Percutaneous Nephrolithotomy
- Without reverse insertion of a ureteral catheter
-
Hengyang, Hunan, ChinaThe First Affiliated Hospital of University of South China
Nov 6, 2022
SARS-CoV-2 Trial (SARS-CoV-2 mRNA Vaccine, Bivalent Low dose, SARS-CoV-2 mRNA Vaccine, Bivalent High dose, Placebo)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 mRNA Vaccine, Bivalent Low dose
- +2 more
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Jan 3, 2023
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, mRNA-1273)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E
- mRNA-1273
- (no location specified)
Apr 25, 2022
Pancreatic Duct Stone, ESWL, Fasting Trial in Shanghai (Early feeding group, Standard fasting group)
Not yet recruiting
- Pancreatic Duct Stone
- +2 more
- Early feeding group
- Standard fasting group
-
Shanghai, ChinaChanghai Hospital
Dec 20, 2022
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
Coronavirus Infections, Pneumonia, Viral Trial in Parma (Colchicine)
Completed
- Coronavirus Infections
- Pneumonia, Viral
-
Parma, PR, ItalyAzienda Ospedaliero Universitaria di Parma
Jul 19, 2022
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
SARS-CoV-2 Trial in Bengbu (COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose, COVID-19 Variant (Omicron BA.5) mRNA Vaccine
Recruiting
- SARS-CoV-2
- COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose
- +2 more
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Jan 3, 2023
COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)
Recruiting
- COVID-19
- mRNA-1283.222
- mRNA-1273.222
-
Birmingham, Alabama
- +209 more
Apr 13, 2023
COVID-19 Pandemic Trial (Lyophilized COVID-19 mRNA Vaccine, Sodium chloride)
Not yet recruiting
- COVID-19 Pandemic
- Lyophilized COVID-19 mRNA Vaccine
- Sodium chloride
- (no location specified)
Nov 18, 2022
COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)
Not yet recruiting
- COVID-19
- mRNA-CR-04 vaccine 10μg
- +3 more
-
San Diego, California
- +3 more
Aug 1, 2023
COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 variant Vaccine (Sf9 Cell)
- +3 more
-
Morelia, Michoacán De Ocampo, MexicoClínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022
Severe Exacerbation of Severe Acute Respiratory Syndrome
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co. Ltd.,
Jun 5, 2023
Kidney Stone, Ureteral Stone Trial in Denmark, Portugal, United States (SOLTIVE™ Premium SuperPulsed Laser Fiber System)
Recruiting
- Kidney Stone
- Ureteral Stone
- SOLTIVE™ Premium SuperPulsed Laser Fiber System
-
Phoenix, Arizona
- +6 more
Jan 16, 2023
Japan After Severe Acute Respiratory Syndrome Coronavirus 2
Not yet recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd
Jun 6, 2023
Gout Arthritis Trial in Lyon
Not yet recruiting
- Gout Arthritis
-
Lyon, FranceCentre Hospitalier Saint Joseph Saint Luc
Feb 22, 2023
COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))
Not yet recruiting
- COVID-19
- XBB.1.5 Vaccine (Booster)
- XBB.1.5 Vaccine (single dose)
-
Mobile, Alabama
- +29 more
Aug 4, 2023
SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- Influenza
- mRNA-1073
- +3 more
-
Hollywood, Florida
- +13 more
Oct 5, 2022
Chronicization of Radiation-induced Acute Intestinal Injury
Not yet recruiting
- Radiation-induced Intestinal Injury
- NCRT+TME
- (no location specified)
Feb 19, 2023
Antibody Response to COVID19 Vaccination in Multiple Sclerosis
Completed
- Multiple Sclerosis
- Covid19
-
Livingston, New JerseySaint Barnabas Medical Center
Aug 16, 2022
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
Advanced Gastric Carcinoma, Immunotherapy Trial in Beijing (Circulating exosomal lncRNA-GC1 detection)
Completed
- Advanced Gastric Carcinoma
- Immunotherapy
- Circulating exosomal lncRNA-GC1 detection
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Oct 7, 2022
SARS-CoV-2 Trial (LVRNA009, 0.9%NaCl)
Not yet recruiting
- SARS-CoV-2
- LVRNA009
- 0.9%NaCl
- (no location specified)
Jan 11, 2023
SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)
Not yet recruiting
- SARS-CoV2 Infection
- Coronavirus Infection
- mRNA- COVID-19
- Prevnar13
-
Hamilton, Ontario, CanadaMcMaster University
Jun 29, 2022
Pneumococcal Infection Trial in Puerto Rico, United States (V110, V114, mRNA-1273)
Recruiting
- Pneumococcal Infection
- V110
- +4 more
-
North Hollywood, California
- +45 more
Aug 11, 2022